Ambily Banerjee Ph.D | Global Head of Clinical Development Equity, Novartis

Photograph of Ambily BanerjeeAfter a decade as an academic scientist, following a Ph.D. in Molecular Biology, Ambily moved to GSK Regulatory Affairs.

Whilst leading GSK’s UK Brexit preparations for Regulatory Affairs across all of GSK’s Business Units, Ambily led a race and ethnicity Employee Resource Group, where she worked with the CEO, Chief Executive Team and Board members to implement global changes to ensure equity for ethnic minorities. In Nov 2021, she moved to Novartis, to focus on Clinical Trial Diversity. Externally, Ambily is the Deputy Chair of The Network of Networks (TNON), which brings together ERG leads from 120+ organisations to share best practices on driving race equity. Ambily serves on the Board of a not-for-profit ‘Micro:bit Educational Foundation’ (founded by the BBC) improving tech skills for under-represented populations. She is passionate about DEI and ensuring the next generation have equal access to opportunities.